Sera Prognostics, Inc. (SERA): Shareholders' Equity
$75.41M
As of 2025-12-31
$59.38M
As of 2026-06-30
-8.7%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $75.41M | +57.7% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $47.80M | -31.9% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $70.16M | -29.1% | 2025-03-19, Balance as of period end |
| 2022-12-31 | $98.94M | -28.6% | 2024-03-20, Balance as of period end |
| 2021-12-31 | $138.56M | n/m | 2023-03-22, Balance as of period end |
| 2020-12-31 | -$125.57M | n/a | 2022-03-29, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $75.41M | +57.7% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $12.84M | n/m |
| YD Bio Ltd (YDES) | 2025-12-31 | -$2.86M | n/m |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $8.61M | +3.5% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.69M | -7.8% |
| CapForce Inc. (CFOR) | 2025-12-31 | $31.86M | +331.6% |
| Exagen Inc. (XGN) | 2025-12-31 | $17.45M | +82.9% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $261.19M | +28.7% |
| Biodesix Inc (BDSX) | 2025-12-31 | -$2.46M | n/m |
Compare SERA, ACON, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗